cdk4/6 inhibitors making the difference ” dr. ahmed saadeddin
Published 3 years ago • 128 plays • Length 23:28Download video MP4
Download video MP3
Similar videos
-
26:40
cdk 4/6 inhibition in early breast cancer by dr. ahmed saadeddin 18-6-2021 (day1)
-
17:31
survival analysis of of cdk4/6 inhibitors andendocrine therapy in hr positive,her2 negative day1
-
17:00
treatment of disease progression after first line cdk4/6 inhibitors by dr. omalkhair abulkhair
-
7:58
cdk 4/6 inhibitors: how are they used in metastatic breast cancer treatment?
-
7:59
what are cdk 4/6 inhibitors for breast cancer?
-
4:35
cdk4/6 inhibitors & endocrine therapy: adverse events
-
7:40
cdk4/6 inhibitors in the first-line treatment setting
-
21:35
educational sessions: "cdk4/6 for er "
-
17:54
expert perspectives: cdk 4/6 inhibitors for er breast cancer: current data and clinical use
-
2:31
cdk4/6 inhibitor toxicity management
-
1:02:43
realizing the potential of cdk 4/6 inhibitor therapy in breast cancer: real-world data and evidence
-
29:37
updates of cdk4/6 inhibitors
-
5:01
cdk4/6 inhibitors: sequencing endocrine therapy for metastatic breast cancer
-
3:33
cdk 4/6 inhibitors in metastatic breast cancer
-
29:09
interactive case: choosing and using cdk4/6 inhibitors in breast cancer - first-line therapy
-
31:32
atlas and cdk4/6 inhibitor trials presented by dr. john smith ii, compass oncology
-
5:38
cdk4/6 inhibitors in metastatic breast cancer
-
4:54
monarch 3 study: cdk4/6 inhibitors in the treatment of metastatic breast cancer
-
1:41
dr. harold j. burstein on cdk4/cdk6 inhibitor abemaciclib in breast cancer